ASCO Annual Conference: Highlights in Pancreatic Cancer Research
Dr. Allyson Ocean reviews some of the latest pancreatic cancer research results, including new treatments for some patients.
New Study Focuses On Supportive Oncology Care At Home
For some newly diagnosed patients with borderline resectable tumors or locally advanced disease, neoadjuvant therapy is proving to be a…
Combination Delivers a Dual Punch to Pancreatic Cell Growth
Dr. Conan Kinsey outlines a clinical trial that has moved quickly from the lab to phase I, with a dual approach to delivering pancreatic cancer treatment.
MRI-Guided Radiation: A New Option for Pancreatic Cancer Treatment
Dr. Parag Parikh and others are using MRI-guided radiation to provide precision radiation treatment for pancreatic cancer.
Pancreatic Microbiome May Hold the Key To Better Treatment
Dr. Deirdre Cohen's research into the pancreatic microbiome has found that gut bacteria may directly influence the effectiveness of immunotherapy.
A PARP Inhibitor Approval for Pancreatic Cancer
PARP inhibitors, a type of targeted therapy, are being studied as treatment for pancreatic cancer in a number of clinical trials.
Pancreatic Cancer: 2018 Highlights And Looking Forward to 2019
Dr. Allyson Ocean leads an overview of the new treatments and protocol from 2018 as well as what are the next steps in treatment for 2019.
Aiming to Improve Immunotherapy for Pancreatic Cancer
One particular area of interest: improving immunotherapy, a treatment that has shown to be effective in many cancers but, so…
Targeting AXL May Improve Chemotherapy for Pancreatic Cancer
Dr. Shaalan Beg describes a clinical trial using the kinase inhibitor bemcentinib along with chemotherapy as a way to slow down or stop pancreatic cancer.
PARP Inhibitors for Pancreatic Cancer Maintenance Treatment
But newer approaches like targeted therapies take aim at very specific genetic changes and the proteins within cancer cells that…
